
Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease
Keywords: Adenosine A2A receptor; Caffeine; Dyskinesia; Neuroprotection; Parkinson's disease; Striatum; 6-OHDA; 6-hydroxydopamine; ACh; acetylcholine; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; APEC; 2-[(2-aminoethylamino)carbonylethyl-phenylethyl